The pharma giant is betting that Blueprint, whose research revolves around a certain kind of tyrosine kinase, will be a boost ...

Bristol Myers Squibb (BMS) is joining forces with BioNTech in a deal that could surpass $11bn as the two drugmakers look to ...

These mutated diseases defy the power of antibiotics. Are illnesses really mutating so fast that we can’t stay ahead of them?

MANCHESTER UNITED are set to undergo a huge change during the summer transfer window. The Red Devils are reportedly ...

Instead of receiving uncomfortable eye injections around once a month for a disease that can lead to blindness, patients may ...